The same drug that has slowed and reversed the progression of motor neurone disease has been found to yield similar benefits for Parkinson’s disease patients, according to the results of a new trial led by the Royal Melbourne Hospital.
Findings from an international clinical trial involving Australian researchers show a drug that targets the immune system can delay type 1 diabetes (T1D) by two years in children and adults at high risk.
Melbourne Health CEO Professor Christine Kilpatrick has been recognised for her service to the medical community with the title of Officer of the Order of Australia (AO) as part of the Queen’s Birthday Honours list.
Six new mums with Phenylketonuria (PKU) have met at the Royal Melbourne Hospital for the first time to talk about managing their genetic condition while pregnant.
Last week, RMH celebrated National Volunteer Week, where we commemorated Australia’s almost 6 million volunteers. This year's theme is “Making a World of Difference.”
A new clinic to help treat patients with genetic eye conditions has opened at The Royal Victorian Eye and Ear Hospital as a partnership between The Royal Victorian Eye and Ear Hospital and The Royal Melbourne Hospital.
A team of Melbourne researchers have found the time to treat ischemic stroke patients can be doubled. One in five people suffer stroke in their sleep and this will be life changing for them.
